It is important to recognize that the direction of changes for plasma protein levels of complement C3, C4, and ACLA-IgG among aPL-positive patients with SLE and with thrombosis or pregnancy morbidity are mostly opposite to each other. The gene discussed is C3; the disease is deep vein thrombosis.